Snowball logo
logo
6472

BORA PHARMACEUTICALS LTD

6472 โ€ข TW
NT$421.50-NT$14.50ย  (3.33%)
Estimate
P/E
35.9
EPS
11.74
Beta
0.444
Growth
Revenue, YoY
20.99%
Net income, YoY
-9.88%
FCF, YoY
-67.55%
Forecast
P/E (FWD)
10
EPS (FWD)
42.054
Dividends
Dividend yield
2.37%
Annual payout
NT$10.00
Next ex. div date
July 31, 27
Payout
93.66%
Div.growth, 5y
74.57%
Div.rating
About the company
Ticker
6472
ISIN
TW0006472004
Country
Taiwan
Sector (GICS)
Other
Bora Pharmaceuticals Co., LTD. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibiotics, and gastrointestinal medications; and nutritional and vitamin supplements, physical recovery, and health care products. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei City, Taiwan.

Frequently asked questions

What sector does BORA PHARMACEUTICALS LTD (6472) operate in?

BORA PHARMACEUTICALS LTD belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is BORA PHARMACEUTICALS LTD (6472) current stock price?

As of the latest data, BORA PHARMACEUTICALS LTD stock price is NT$421.50, with a previous close of NT$436.00. BORA PHARMACEUTICALS LTD lost -NT$14.50 in the last trading session, representing a -3.33% loss.

What is BORA PHARMACEUTICALS LTD (6472) current market capitalization?

BORA PHARMACEUTICALS LTD market cap is approximately 53.76 billion.

What is BORA PHARMACEUTICALS LTD (6472) Earnings Per Share (EPS)?

The trailing EPS is NT$11.74, and the forward EPS is NT$42.05.

What is BORA PHARMACEUTICALS LTD (6472) Price-to-Earnings (P/E) ratio?

BORA PHARMACEUTICALS LTD current P/E ratio is 35.9, with a forward P/E of 10.02.

What is BORA PHARMACEUTICALS LTD (6472) EBITDA?

BORA PHARMACEUTICALS LTD EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.31 billion.

Does BORA PHARMACEUTICALS LTD (6472) pay dividends?

Yes. BORA PHARMACEUTICALS LTD pays annual dividends with an annualized yield of 2.37% and an estimated annual payout of NT$10.00 per share.

When is the next ex-dividend date for BORA PHARMACEUTICALS LTD (6472)?

The next ex-dividend date is scheduled for July 31, 2027.

How did BORA PHARMACEUTICALS LTD (6472) perform in its most recent earnings report?

In the last report (June 30, 2026), BORA PHARMACEUTICALS LTD posted an EPS surprise of -26% and a revenue surprise of 6.1%.

What is BORA PHARMACEUTICALS LTD (6472) beta (volatility) score?

BORA PHARMACEUTICALS LTD has a beta of 0.444, indicating lower volatility than the overall market.